Question 1

What are the most cited papers from Oculis (Iceland)?

Accepted Answer

The most cited paper from Oculis (Iceland) is "Topical dexamethasone γ‐cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema" (Akihiro Ohira, Katsunori Hara, Gauti Jóhannesson et al., 2015), with 96 citations. Next come "Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits" (48) and "Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment" (44).

Question 2

Which research topics does Oculis (Iceland) publish most on?

Accepted Answer

By volume in 2022-now: Analytical Chemistry and Chromatography, Drug Solubulity and Delivery Systems, Crystallization and Solubility Studies and Advanced Drug Delivery Systems.

Question 3

Which fields of science does Oculis (Iceland) work in?

Accepted Answer

In all years, 35% of research at Oculis (Iceland) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (34%), Pharmacology, Toxicology and Pharmaceutics (22%), Economics, Econometrics and Finance (11%). It does 1.3× the world's share of Life Sciences.

Question 4

Is Oculis (Iceland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 68% lower than in 2018-2021.